{
  "primary": "ATXN3",
  "interaction_type": "direct",
  "upstream_interactor": null,
  "mediator_chain": [],
  "depth": 1,
  "support_summary": "FBXL3, a component of the SKP1-Cullin-F-box (SCF) ubiquitin ligase complex, was identified in a druggable genome screen as a modulator of ATXN3 levels, suggesting it is involved in the ubiquitin-dependent degradation of ATXN3.",
  "functions": [
    {
      "function": "ATXN3 Degradation",
      "arrow": "activates",
      "cellular_process": "FBXL3 is an F-box protein that serves as a substrate recognition component of the SKP1-Cullin1-F-box (SCF) E3 ubiquitin ligase complex. This complex targets specific proteins for ubiquitination, marking them for subsequent degradation by the proteasome.",
      "effect_description": "FBXL3 mediates the ubiquitination and subsequent proteasomal degradation of ATXN3. Overexpression of FBXL3 leads to a reduction in both wild-type and pathogenic ATXN3 protein levels, and this effect is dependent on the SCF complex component CUL1. This indicates that FBXL3 is a key regulator of ATXN3 protein turnover.",
      "biological_consequence": [
        "FBXL3, as part of the SCF complex, recognizes and binds to ATXN3 → The SCF-FBXL3 complex polyubiquitinates ATXN3 → Ubiquitinated ATXN3 is targeted to the proteasome for degradation → Cellular levels of ATXN3 protein are reduced."
      ],
      "specific_effects": [
        "Overexpression of FBXL3 reduces the levels of both wild-type and mutant ATXN3 proteins.",
        "The FBXL3-mediated reduction of ATXN3 levels occurs at the protein level, not the transcriptional level.",
        "The degradation of ATXN3 by FBXL3 is dependent on the presence of CUL1, a core component of the SCF ubiquitin ligase complex."
      ],
      "evidence": [
        {
          "paper_title": "Druggable genome screen identifies new regulators of the abundance and toxicity of ATXN3, the Spinocerebellar Ataxia Type 3 disease protein",
          "journal": "PLoS Genetics",
          "year": 2021,
          "relevant_quote": "If FBXL3 knockdown increases ATXN3 abundance, then its overexpression would be expected to decrease ATXN3 protein levels. Indeed, exogenous FBXL3 in SCA3 NPCs reduced the levels of both wild-type and pathogenic ATXN3 in a SCF- and CUL1-dependent manner, confirming that ATXN3 is a bona fide substrate of the SCFFBXL3 ubiquitin ligase complex.",
          "pmid": "31783119"
        }
      ],
      "pathway": {
        "name": "Ubiquitin-Proteasome System",
        "canonical_name": "Ubiquitin-Proteasome System",
        "ontology_id": null,
        "ontology_source": null,
        "confidence": 0.8
      },
      "pmids": [
        "31783119"
      ],
      "interaction_effect": "activates",
      "interaction_direction": "primary_to_main",
      "function_effect": "activation"
    }
  ],
  "arrow": "inhibits",
  "direction": "main_to_primary",
  "intent": "regulation",
  "arrows": {
    "main_to_primary": [
      "activates"
    ]
  },
  "is_valid": true,
  "mechanism_correction": null,
  "mechanism": "FBXL3 is an F-box protein that serves as a substrate recognition component of the SKP1-Cullin1-F-box (SCF) E3 ubiquitin ligase complex. This complex targets specific proteins for ubiquitination, marking them for subsequent degradation by the proteasome.",
  "effect": "FBXL3 mediates the ubiquitination and subsequent proteasomal degradation of ATXN3. Overexpression of FBXL3 leads to a reduction in both wild-type and pathogenic ATXN3 protein levels, and this effect is dependent on the SCF complex component CUL1. This indicates that FBXL3 is a key regulator of ATXN3 protein turnover.",
  "summary": "ATXN3 activates FBXL3 to modulate atxn3 degradation, ultimately affecting cellular levels of atxn3 protein are reduced.",
  "evidence": [
    {
      "paper_title": "Druggable genome screen identifies new regulators of the abundance and toxicity of ATXN3, the Spinocerebellar Ataxia Type 3 disease protein",
      "journal": "PLoS Genetics",
      "year": 2021,
      "relevant_quote": "If FBXL3 knockdown increases ATXN3 abundance, then its overexpression would be expected to decrease ATXN3 protein levels. Indeed, exogenous FBXL3 in SCA3 NPCs reduced the levels of both wild-type and pathogenic ATXN3 in a SCF- and CUL1-dependent manner, confirming that ATXN3 is a bona fide substrate of the SCFFBXL3 ubiquitin ligase complex."
    }
  ],
  "pathways": [
    {
      "name": "Ubiquitin-Proteasome System",
      "canonical_name": "Ubiquitin-Proteasome System",
      "ontology_id": null,
      "ontology_source": null,
      "confidence": 0.8
    }
  ],
  "interaction_effect": "inhibition",
  "_validation_metadata": {
    "validated": true,
    "validator": "arrow_effect_validator",
    "corrections_applied": 3
  },
  "_arrow_validated": true,
  "arrow_notation": "ATXN3 <--inhibits-- FBXL3:",
  "protein_a": "FBXL3",
  "protein_b": "ATXN3",
  "discovered_in_query": "ATXN3",
  "first_discovered": "2025-12-01T05:51:49.796781Z",
  "last_updated": "2025-12-01T05:51:49.796781Z"
}